Furthermore, CXCR5+CD8 T cells appear resistant to immune checkpoint blockade therapy (ICB) induced apoptosis compared to susceptible CXCR5−CD8 T cells and, instead, demonstrate an effector-like phenotype in infection and chronic lymphocytic leukemia (11, 27). This evidence concerns the gene CD8A and infection.